Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects.

J Allergy Clin Immunol Pract

Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Internal Medicine, University of California, San Francisco, Calif. Electronic address:

Published: May 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897836PMC
http://dx.doi.org/10.1016/j.jaip.2022.02.030DOI Listing

Publication Analysis

Top Keywords

immunogenicity third
4
third covid-19
4
covid-19 messenger
4
messenger rna
4
rna vaccine
4
vaccine dose
4
dose primary
4
primary immunodeficiency
4
immunodeficiency disorder
4
disorder patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!